newsletter Conference News

Keypoint Newsletter: Fall Line-Up Kicks off with Long- COVID, and exclusive NPR Coverage!

Our fall line-up of conferences is off to a great start, featuring many emerging and hot topics, from longcovid to next-generation nanomedicines, regulatory RNAs, vaccinology and more! (see listing below)  In  particular, the Long COVID and Post-Acute Sequalae of SARS CoV-2: Pathogenesis and Treatment conference made a big splash in the news media, with NPR reporter Will Stone in attendance (see NPR & BBC coverage below!).  Held in Santa Fe from August 27 to 30, it was the first meeting of its kind to gather researchers from across diverse disciplines to discuss emerging research on the causes of this mysterious post-pandemic illness.  From mitochondrial pathology to pulmonary, neurological and metabolic impacts, the meeting integrated a wide range of research to identify disease drivers and causes of systemic and inexplicable symptoms. Attendees were enthusiastic about the array of insights from talks, and personal connections made to advance scientific and clinical research for the benefit of patients. (Get On Demand Access for the meeting!)
Find out more about meeting highlights below, with our exclusive interviews with Long COVID and Next-Generation Nanomedicines conference organizers, as they answer our burning questions about their meeting, the latest discoveries in the field and future directions. 

Long COVID and Post Acute Sequalae of SARS CoV-2 (PASC): Pathogenesis and Treatment

Dr. Steven Deeks discusses the emerging research on mechanisms and pathology behind the mysterious illness of long COVID, as well as emerging treatments that was covered in the conference in August.

See the meeting program & get On Demand Access here
Meeting Highlights:
  • Keynote Address by Gary H. Gibbons, NHLBI, National Institutes of Health,
    RECOVER Initiative: Progress and Future Directions
  • Immunopathology, including autoantibodies, neuroinflammation and immunophenotyping in patients
  • Vascular, pulmonary and cardiac dysfunction, and impacts on various organ systems
  • Lessons learned from other post-infectious syndromes, including lyme disease, EBV, and chronic fatigue syndrome
  • Disease management and emerging treatments

Listen to NPR & BBC Coverage of the Meeting! 

See more social media posts at:


Co-organizers Dr. Resia Pretorius and Dr.Catherine Blish wrap up the meeting with reflections on scientific insights and impacts on the community


Next-Generation Nanomedicine

Virtual, September 6-8

Dr. Philip Felgner shares insights into how the field has gone from inception to application since he first organized a Keystone Symposia on the topic in 1998, and now 25 years later looking ahead to the new therapeutic potential that lies within reach.


Meeting Highlights:
  • Keynote Address by Pieter Cullis, University of British Columbia
    Rational Design of Lipid Nanoparticle Delivery Systems for Nucleic Acid-Based Drugs
  • Novel delivery technologies and tissue targeting approaches to overcome current limitations
  • Machine learning and AI approaches to revolutionize nanomedicine capabilities
  • Advances in mRNA Vaccines and immunoengineering
  • Clinical applications beyond vaccines
Check out the meeting program and get On Demand Access here

Hear Dr. Felgner's insights on the field overall here

Aug 27 - 30, 2023 Long COVID and Post Acute Sequalae of SARS CoV 2 (PASC): Pathogenesis and Treatment Santa Fe, New Mexico
Sep 03 - 06, 2023 Transposable Elements at the Crossroads of Evolution, Health and Disease Whistler, BC, Canada
Sep 06 - 08, 2023 Next-Generation Nanomedicine Virtual
Sep 17 - 20, 2023 Vaccinology During and After COVID-19 Atlanta, Georgia
Oct 01 - 04, 2023 B Cells and Tertiary Lymphoid Structures: Emerging Targets in Cancer Therapeutics Whistler, British Columbia, Canada
Oct 01 - 04, 2023 Immunity and Aging Whistler, BC, Canada
Oct 01 - 04, 2023 T and B Cell Collaboration in Germinal Centers and Beyond Whistler, BC, Canada
Oct 08 - 11, 2023 Circulating Metabolic Intermediates as Fuels and Signals

Snowbird, Utah

Oct 08 - 11, 2023 Mechanisms of Microbiota-Immune Interactions-Towards the Next Decade Snowbird, Utah
Dec 03 - 06, 2023 Autophagy and Disease Keystone, Colorado
Dec 03 - 06, 2023 Ubiquitin Biology and Disease Keystone, Colorado
Dec 12 - 15, 2023 Regulatory RNAs: Emerging Mechanisms Banff, Alberta, Canada
Dec 12 - 15, 2023 RNA Modifications in Health and Disease Banff, Alberta, Canada
See the full 2024 season roster here


donate banner (1)


Return to the September 2023 Keypoint Newsletter




Shannon Weiman
Shannon Weiman earned her PhD in Biomedical Sciences from the University of California, San Diego, specializing in microbiology and immunology. Prior to joining the Keystone Symposia team, she worked as a freelance writer for leaders in academic, industry and government research, including Stanford University’s Biomedical Innovation Initiative, the University of Colorado’s Biofrontiers Program, UCSF, the FDA and the American Society for Microbiology.